 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company NASDAQ: ANIP today announced business highlights and financial results for the three months ended March 31, 2021. First Quarter and Recent Business Highlights: Continued efforts to assemble a robust re-filing package for Cortrophin Gel in preparation for second-quarter 2021 submission to the U.S. Food and Drug Administration FDA. Signed a definitive agreement to acquire Novitium Pharma LLC Novitium, 